December 18, 2024 CER 0 Comments Can we measure this? – Healthcare Economist A paper by Kowal et al. (2023) does in fact measure the disparities in health outcomes. To do this, they use data from the ... Read More
July 31, 2024 Adverse Event 0 Comments Methods for Including Adverse Events in Economic Evaluations – Healthcare Economist That is the title of a great review paper by Salah Ghabri, Dalia Dawoud and Michael Drummond. They discuss that guidance on the incorporation ... Read More
July 2, 2024 Broader Value Elements 0 Comments HTA and cell and gene therapy – Healthcare Economist A paper by Drummond et al. (2023) examines how health technology assessment bodies deal with the challenge of value ... Read More
June 5, 2024 Comparative Effectiveness 0 Comments Challenges in Conducting Economic Evaluations for Orphan Drugs in Rare Diseases – Healthcare Economist Why is it so hard to estimate the value of orphan drugs indicated for the treatment of rare diseases? ... Read More